TPG Group Holdings (SBS) Advisors, Inc.
Institutional investor · Portfolio as of Q4 2014
Top Holdings38 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
1793264 | 196.1M | $4.9B | 30.2% | — | — | 1 qtr | New 99 |
12571 | 159.7M | $4.1B | 25.0% | — | — | 1 qtr | New 99 |
SABRE CORP | 151.2M | $3.1B | 18.7% | $17.75 | 0.00% | 1 qtr | New 99 |
Surgical Care Affiliates, Inc. | 23.9M | $805.6M | 4.9% | — | — | 1 qtr | New 89 |
NORWEGIAN CRUISE LINE HOLDIN | 16.1M | $751.9M | 4.6% | $46.86 | 0.00% | 1 qtr | New 89 |
| 11.2M | $659.8M | 4.0% | — | — | 1 qtr | New 88 | |
LPL FINANCIAL HOLDINGS INC | 12.9M | $574.1M | 3.5% | $38.17 | 0.00% | 1 qtr | New 88 |
| 23.7M | $435.2M | 2.7% | — | — | 1 qtr | New 82 | |
| 8.7M | $166.5M | 1.0% | — | — | 1 qtr | New 70 | |
AV Homes Inc. | 9.2M | $134.3M | 0.8% | — | — | 1 qtr | New 60 |
Ultragenyx Pharmaceutical, Inc. | 2.1M | $92M | 0.6% | $44.04 | 0.00% | 1 qtr | New 59 |
| 2.5M | $72.4M | 0.4% | — | — | 1 qtr | New 50 | |
Otonomy, Inc. | 2.2M | $72M | 0.4% | — | — | 1 qtr | New 50 |
AERIE PHARMACEUTICALS INC | 2.1M | $60.9M | 0.4% | — | — | 1 qtr | New 50 |
Sixth Street Specialty Lending, | 3.2M | $54.4M | 0.3% | $5.45 | 0.00% | 1 qtr | New 50 |
Veracyte, Inc. | 3.6M | $34.3M | 0.2% | $9.52 | 0.00% | 1 qtr | New 49 |
Tandem Diabetes Care, Inc. | 2.5M | $31.7M | 0.2% | — | — | — | — |
FIVE PRIME THERAPEUTICS INC | 1.1M | $28.5M | 0.2% | — | — | 1 qtr | New 49 |
INTERACTIVE BROKERS GRO-CL A | 958,702 | $28M | 0.2% | $6.76 | 0.00% | 1 qtr | New 49 |
VERINT SYSTEMS INC | 477,084 | $27.8M | 0.2% | — | — | 1 qtr | New 49 |
TPG Group Holdings (SBS) Advisors, Inc. manages $16.4B across 38 positions as of Q4 2014. Top holdings: FSL (30.2%), IMS (25.0%), SABR (18.7%). Fund DNA: Balanced Allocator.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer